Controlled Research of the Treatment of the Malignant Biliary |Obstruction Jaundice by Percutaneous Transhepatic Route and the |Duodenoscopic Approach Biliary Stent Placement
HUANG Renping
The People's Hospital of Gaozhou, Guangdong Gaozhou 525200, China
Abstract：Objective: To investigate the clinical efficacy of the treatment of malignant biliary obstruction jaundice by percutaneous transhepatic route and duodenoscopic approach biliary stent placement. Methods: 110 patients with malignant biliary obstructive jaundice from December 2013 to March 2015 accepted in our hospital, were divided into experimental group and control group by the random number table method, 55 cases in each group. After admission to hospital, patients in the two groups before operation were given hepatoprotective, diuretic and anti infection etc., improve the patient's general condition. Patients in the experimental group were treated by percutaneous transhepatic biliary stent implantation, and the control group were treated by endoscopic biliary stent implantation. The levels of total bilirubin (TB), direct bilirubin (DB), indirect bilirubin (IB), the average survival period, complication rate and total efficiency of the treatment between the two groups before and after treatment were observed and compared. after treatment. Results: After treatment, compared with before treatment, the TB, DB and IB levels were decreased, the difference was statistically significant (P < 0.05); Compared with the control group, TB, DB, IB levels were lower in patients of the experimental group than that in control group, the difference was statistical significance (P < 0.05); Compared with the control group, postoperative average survival period was longer in patients of the experimental group than that in control group, the difference was statistical significance (P < 0.05); Compared with the control group, the incidence of complications in patients of the experimental group were lower, clinical effective rate was higher, and the difference was statistically significant (P < 0.05). Conclusion: The clinical efficacy of the percutaneous transhepatic route in the treatment of malignant biliary obstruction is better than duodenoscopic approach biliary stent placement, more conducive to reduced levels of bilirubin, prolong the survival of patients, improve the treatment efficacy.
廖均平, 梁日光, 梁永任, 欧光武, 刘杰文. 经肝穿刺与经十二指肠镜途径胆道支架置入治疗恶性胆道梗阻性黄疸的对照研究[J]. 河北医学, 2017, 23(10): 1602-1604.
HUANG Renping. Controlled Research of the Treatment of the Malignant Biliary |Obstruction Jaundice by Percutaneous Transhepatic Route and the |Duodenoscopic Approach Biliary Stent Placement. 河北医学, 2017, 23(10): 1602-1604.
[1]夏宁,程永德,王忠敏.胆道支架再狭窄的介入治疗进展[J].介入放射学杂志,2014,23(1):82~85. [2] 鲁东,吕维富,肖景坤,等.经皮肝穿刺胆道腔内射频消融联合支架植入治疗恶性梗阻性黄疸(附2例报告)[J].介入放射学杂志,2014,23(7):593~596. [3] 崔宁,李晓群.经皮经肝双极射频消融导管恶性梗阻性黄疸20例[J].介入放射学杂志,2014,23(8):693~697. [4] Ullah AA, Rahman A, Chowdhury LH,et al. Improvement of liver function, quality of life and survival after insertion of endoprosthesis in advance malignant biliary obstruction[J].Mymensingh Med, 2017,26(1):92~103. [5] 贾志贤.经皮经肝胆管穿刺引流术与胆管支架置入术治疗恶性梗阻性黄疸的疗效评价[J].海南医学院学报,2014,3(19):374~377. [6] 仲捷,刘好田,王彦华,等.经皮肝穿刺胆道引流术+胆道支架置入术治疗高位恶性梗阻性黄疸疗效观察[J].山东医药,2014,14(21):70~71. [7] Almadi MA, Barkun JS, Barkun AN. Stenting in malignant biliary obstruction[J].Gastrointest Endosc Clin N Am,2015,25(4):691~711. [8] Yamamoto R, Takahashi M, Osafune Y, et al. Comparison of endoscopic stenting for malignant biliary obstruction: A single-center study[J].World Gastrointest Endosc, 2015,7(9):889~894. [9] Song TJ, Lee JH, Lee SS,et al. Metal versus plastic stents for drainage of malignant biliary obstruction before primary surgical resection[J].Gastrointest Endosc,2016,84(5):814~821. [10] Miura S, Kanno A, Masamune A, et al. Risk factors for recurrent biliary obstruction following placement of self-expandable metallic stents in patients with malignant perihilar biliary stricture[J].Endoscopy, 2016,48(6):536-545.
2017, Vol. 23 
冀公网安备13080202000677号